The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.

ABSTRACT:

Objective

To assess the economic burden of epithelial ovarian cancer (EOC) in incident patients and the burden by disease stage in Spain.

Methods

We developed a Markov model from a social perspective simulating the natural history of EOC and its four stages, with a 10-year time horizon, 3-week cycles, 3% discount rate, and 2016 euros. Healthcare resource utilization and costs were estimated by disease stage. Direct healthcare costs (DHC) included early screening, genetic counselling, medical visits, diagnostic tests, surgery, chemotherapy, hospitalizations, emergency services, and palliative care. Direct non-healthcare costs (DNHC) included formal and informal care. Indirect costs (IC) included labour productivity losses due to temporary and permanent leaves, and premature d

SUBMITTER: Delgado-Ortega L 

PROVIDER: S-EPMC6394604 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature